Scancell (LON:SCLP) Stock Passes Below Two Hundred Day Moving Average – Here’s Why

Scancell Holdings plc (LON:SCLP)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 11.06 ($0.14) and traded as low as GBX 7.80 ($0.10). Scancell shares last traded at GBX 8.07 ($0.10), with a volume of 1,411,764 shares traded.

Scancell Price Performance

The stock has a market cap of £83.53 million, a P/E ratio of -12.37 and a beta of 0.35. The business’s 50 day moving average price is GBX 8.53 and its two-hundred day moving average price is GBX 11.06. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of -566.79.

Scancell (LON:SCLP) last posted its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share for the quarter. As a group, sell-side analysts expect that Scancell Holdings plc will post -2.5361112 earnings per share for the current fiscal year.

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.